IJE Advance Access originally published online on January 13, 2005
International Journal of Epidemiology 2005 34(1):87-88; doi:10.1093/ije/dyh406
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
IJE vol.34 no.1 © International Epidemiological Association 2005; all rights reserved.
Commentary |
Commentary: Empirical evidence of attrition bias in clinical trials
1 Department of Social and Preventive Medicine, University of Berne, Finkenhubelweg 11, CH-3012 Bern, Switzerland
2 MRC Health Services Research Collaboration, Department of Social Medicine, University of Bristol, Canynge Hall, Whiteladies Road, Bristol BS8 2PR, UK
* Corresponding author. Department of Social and Preventive Medicine, University of Berne, Finkenhubelweg 11, CH-3012 Bern, Switzerland. E-mail: egger@ispm.unibe.ch
| The first 10% of the full text of this article appears below. |
Excluding the 5 patients who died and the 10 who had permanent postoperative deficits, there remained 79 patients available for follow-up and at risk of subsequent persistent stroke and death.
This is how, in 1970, Fields and colleagues analysed the data from the Joint Study of Extracranial Arterial Occlusion, which had randomly allocated patients with bilateral carotid stenosis to carotid endarterectomy or medical treatment.1 Among the patients who had survived surgery and were available for follow-up, a 26% reduction in the risk of recurrent transient ischaemic attacks, stroke, or death
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
E. Nuesch, S. Trelle, S. Reichenbach, A. W S Rutjes, E. Burgi, M. Scherer, D. G Altman, and P. Juni The effects of excluding patients from the analysis in randomised controlled trials: meta-epidemiological study BMJ, September 7, 2009; 339(sep07_1): b3244 - b3244. [Abstract] [Full Text] [PDF] |
||||
